0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Sign in to save

The greening of diabetes

Practical Diabetes 2023 3 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 35 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Mark Greener

Summary

This article examines efforts by diabetes care stakeholders to reduce the environmental impact of plastics used in diabetes devices and supplies, discussing innovations in device sustainability and the collaborative industry approach emerging to reduce the pharmaceutical sector's plastic footprint. The piece highlights both progress and remaining challenges in greening the materials used for insulin delivery, glucose monitoring, and related diabetes management tools.

Here, Mark Greener discusses the work of key diabetes stakeholders in reducing the environmental footprint left by plastics used in diabetes care, innovations in diabetes device sustainability, and the collaborative approach that is emerging across the pharmaceutical industry for the good of the planet.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Exploring the micro- and nanoplastics–diabetes nexus: Shattered barriers, toxic links, and methodological horizons

This review examines growing evidence that micro- and nanoplastics may contribute to diabetes by disrupting blood sugar regulation, insulin signaling, and fat metabolism through oxidative stress and inflammation. Animal studies show that plastic particles can damage the pancreas, liver, and gut in ways that mirror the development of diabetes, though human studies are still limited. The review calls for more research into whether everyday microplastic exposure could be a hidden factor in the global rise of metabolic diseases.

Article Tier 2

Actionable avenues for dermatologists to reduce their environmental impact

This commentary outlines actionable steps dermatologists can take to reduce the environmental impact of healthcare delivery, including minimizing single-use plastics, reducing regulated medical waste, and implementing green procurement policies. Researchers highlighted opportunities for reassessing procedure kits, minimizing medication waste, and promoting environmentally conscious practices. The study underscores that healthcare settings are significant contributors to plastic waste and offers practical strategies for reducing that footprint.

Article Tier 2

Emerging Contaminants: An Emerging Risk Factor for Diabetes Mellitus

This review examines how emerging environmental contaminants, including microplastics and nanoplastics, may contribute to the development and progression of diabetes. These contaminants can disrupt glucose metabolism through oxidative stress, inflammation, and interference with hormone signaling. The findings suggest that chronic exposure to microplastics and other pollutants in food and water could be an overlooked risk factor for the growing global diabetes epidemic.

Article Tier 2

How Should US Health Care Lead Global Change in Plastic Waste Disposal?

This article argues that US health care must lead global change in plastic waste disposal by assigning accountability to organizational leaders, implementing circular supply chains, and collaborating across medical and waste industries to reduce environmental harm.

Article Tier 2

The Hidden Dangers of Plastic Use in the Food Industry: Implications for Diabetes and Public Health

This review examines health risks from plastic use in food processing and packaging, documenting how microplastics, nanoplastics, and endocrine-disrupting chemicals leach from food contact materials into food and may contribute to immune dysfunction, metabolic disorders, and diabetes risk.

Share this paper